Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database

3,4-Methylenedioxymethamphetamine (MDMA) is currently being evaluated by the Food and Drug Administration (FDA) for the treatment of post-traumatic stress disorder (PTSD). If MDMA is FDA-approved it will be important to understand what medications may pose a risk of drug–drug interactions. The goal...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Isaac V., Makunts, Tigran, Abagyan, Ruben, Thomas, Kelan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966744/
https://www.ncbi.nlm.nih.gov/pubmed/33727616
http://dx.doi.org/10.1038/s41598-021-85389-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966744/
https://www.ncbi.nlm.nih.gov/pubmed/33727616
http://dx.doi.org/10.1038/s41598-021-85389-x

Ejemplares similares